Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. Palantir to Seek Funding on Private Market, Delay IPO

    Bloomberg via Yahoo FinanceSep 05 17:52 PM

    Co-founded by billionaire investor Peter Thiel in 2004, Palantir got its start helping the U.S. Department of Defense and other federal agencies aggregate and analyze mountains of data ...

  2. Merck Sees Hammer Chart Pattern: Time to Buy?

    Zacks via Yahoo FinanceSep 11 13:24 PM

    Merck & Co., Inc. MRK has been struggling lately, but the selling pressure may be coming to an end soon. What is a Hammer Chart Pattern? A hammer chart pattern is a popular ...

  3. ATE.V: Phase 2b Efficacy Data Expected in 4Q19…

    Zacks Small Cap Research via Yahoo FinanceAug 29 13:20 PM

    In March 2019, Antibe Therapeutics Inc. (TSX:ATE.V) announced that the Phase 2b dose-ranging, efficacy study of ATB-346 had commenced. Study subjects will receive once daily doses of ...

  4. MSFT, Merck & Co. Inc. MRK, The Procter & Gamble Co. PG, United Technologies Corp. UTX and The Coca-Cola Co. KO.

  5. Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders ...

  6. Neurotrope shares crash after Alzheimer's drug fails in trial

    Reuters via Yahoo FinanceSep 09 13:20 PM

    Several drugmakers such as Eli Lilly, AstraZeneca Plc, Roche AG, Pfizer Inc, Merck and Co Inc and Johnson and Johnson have all previously failed in their attempts ...

  7. Roche Holding AG RHHBY announced that its new investigational fixed-dose combination (FDC) of Perjeta (pertuzumab) and Herceptin (trastuzumab) has met the primary endpoint of non-inferiority ...

  8. MOVES-Credit Suisse bolsters life sciences banking team -memo

    Reuters via Yahoo FinanceSep 05 22:10 PM

    Credit Suisse Group AG has brought on three new senior investment bankers as it continues to build out its healthcare investment banking division, according to an internal memo reviewed by Reuters ...

  9. Bristol-Myers Squibb Co said on Thursday its blockbuster cancer immunotherapy, Opdivo, failed to meet the main goal of a late-stage trial testing it in patients with a type of tumor that ...

  10. Lululemon Athletica Inc.

  1. Ads
    related to MERCK & CO., INC